Active, Not Recruiting
A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)
NCT06035497
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +26 more
- Locations
-
- Local Institution - 0031 Anjo-shi, Aichi-ken, Japan
- Local Institution - 0011 Nagoya, Aichi-ken, Japan
- Local Institution - 0024 Toyohashi, Aichi-ken, Japan
- Local Institution - 0017 Kamogawa, Chiba, Japan